Regulatory

 

Preparation of regulatory documents including:

• Clinical Overviews
• Summaries of efficacy, safety and clinical pharmacology for CTDs
• Investigator’s Brochures
• Risk Management Plans
• Briefing and Background documents prior to IND/CTA, end of Phase II, pre-MAA/NDA

Devising the Regulatory Strategy

Presentations and Discussions with Regulatory Authorities